Iterum Therapeutics plc (ITRMF) Long-Term Debt Repayments (2020 - 2025)

Iterum Therapeutics' Long-Term Debt Repayments history runs 4 years deep, the most recent figure standing at $14.7 million for Q1 2025.

• In Q1 2025, Long-Term Debt Repayments changed N/A year-over-year to $14.7 million; the TTM figure through Sep 2025 stood at $14.7 million (changed N/A YoY), while the FY2022 annual figure was $2.3 million, down 65.45% from the prior year.
• Long-Term Debt Repayments for Q1 2025 stood at $14.7 million, up from $2.3 million in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $14.7 million in Q1 2025, with the low at $1.6 million in Q1 2021.
• The 3-year median for Long-Term Debt Repayments is $1.6 million (2021), against an average of $3.9 million.
• The sharpest annual moves came in 2021 and 2022: Long-Term Debt Repayments increased 3.23% in 2021, then soared 38.18% in 2022.
• Iterum Therapeutics' Long-Term Debt Repayments stood at $1.6 million in 2021, then jumped by 38.18% to $2.3 million in 2022, then surged by 555.04% to $14.7 million in 2025.
• Business Quant data shows ITRMF's Long-Term Debt Repayments at $14.7 million in Q1 2025, $2.3 million in Q1 2022, and $1.6 million in Q4 2021.